INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/05/2026
Back to search
Official data from USPTO
ESM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/06/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
07/24/2017
Registration date
06/12/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/27/2024
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CROWLEY, SEAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MACROPHAGE PHARMA LIMITED
Representatives
Bryce J. Maynard Buchanan Ingersoll & Rooney PC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposesfor use in oncologyimmunotherapyimmuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease
Class 42
Pharmaceutical research and development services; scientific research services; informationadvisory and consultancy services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/13/2026
INPC
INVALIDATION PROCESSED
02/13/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/27/2025
C71T
CANCELLED SECTION 71
12/27/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/12/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/25/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/17/2018
FIMP
FINAL DISPOSITION PROCESSED
09/17/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/27/2018
PUBO
PUBLISHED FOR OPPOSITION
03/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2018
ALIE
ASSIGNED TO LIE
02/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2018
RFNT
REFUSAL PROCESSED BY IB
01/27/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/07/2018
RFRR
REFUSAL PROCESSED BY MPU
01/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/19/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/17/2017
CNRT
NON-FINAL ACTION WRITTEN
12/16/2017
DOCK
ASSIGNED TO EXAMINER
12/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/14/2017
Continuous trademark protection
Get notified about every new filing that threatens ESM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.